Insider Transactions in Q4 2021 at Adicet Bio, Inc. (ACET)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 10
2021
|
Carl L Gordon |
BUY
Grant, award, or other acquisition
|
Indirect |
214,285
+46.93%
|
$2,999,990
$14.0 P/Share
|
|
Dec 10
2021
|
Orbimed Advisors LLC |
BUY
Grant, award, or other acquisition
|
Indirect |
214,285
+46.93%
|
$2,999,990
$14.0 P/Share
|
|
Dec 08
2021
|
Andrew Sinclair |
BUY
Open market or private purchase
|
Indirect |
500,000
+18.93%
|
$7,000,000
$14.0 P/Share
|
|
Oct 12
2021
|
Blake Aftab Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
80,000
+50.0%
|
-
|
|
Oct 01
2021
|
Brian Nicholas Harvey Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
80,000
+50.0%
|
-
|
|
Oct 01
2021
|
Francesco Galimi SVP & Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
80,000
+47.91%
|
-
|
|
Oct 01
2021
|
Don Healey Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
80,000
+50.0%
|
-
|
|
Oct 01
2021
|
Chen Schor President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
240,000
+50.0%
|
-
|